CDEK
← All trials

NCT06311214

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 20, 2024
Primary completion
Oct 31, 2027
Completion date
Oct 31, 2027
First posted
Mar 15, 2024
Last posted
Oct 9, 2024
Enrollment
500
Arms / groups
4 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.